The global Cancer Immunotherapy Market was valued at USD 153.3 billion in 2025 and is projected to grow from USD 166.4 billion in 2026 to USD 305.8 billion by 2033, registering a CAGR of 9.0% from 2026 to 2033. North America dominated the global market with the largest revenue share of 43.3% in 2025, primarily driven by the increasing prevalence of cancer, continuous innovation in...

The Advanced Therapy Medicinal Products CDMO Market is positioned for remarkable expansion, projected to escalate from a market size of USD 29.97 billion in 2024 to USD 134.73 billion by 2035. This represents a compound annual growth rate (CAGR) of 14.64%, underscoring the increasing significance of contract development and manufacturing organizations (CDMOs) in the biopharmaceutical sector. As...

According to a newly published market research report by 24LifeSciences, global Bruton's Tyrosine Kinase (BTK) inhibitors market was valued at USD 6,941 million in 2024 and is projected to reach USD 9,622 million by 2031, growing at a compound annual growth rate (CAGR) of 4.9% during the forecast period. BTK inhibitors are small molecule therapeutics that selectively inhibit the Bruton's...

" According to the latest report published by Data Bridge Market Research, the Cancer Biological Therapy Market The global cancer biological therapy market size was valued at USD 133.32 billion in 2025 and is expected to reach USD 246.76 billion by 2033, at a CAGR of 8.00% during the forecast period. The supreme Cancer Biological Therapy Market research report has been built by...

The CAR T-Cell Therapy Market research report has been crafted with the most advanced and best tools to collect, record, estimate, and analyze market data. The report also sheds light on the market overview in its entirety touching diverse aspects like product definition, prevailing vendor landscape, and market segmentation. Through the comprehensive and systematic market research study, the...

The CAR-T Cell Therapy Market is experiencing remarkable growth as advanced immunotherapy solutions continue to transform cancer treatment worldwide. Chimeric Antigen Receptor T-cell therapy has emerged as one of the most innovative approaches in oncology, offering personalized treatment options for patients with certain blood cancers. Rising incidences of leukemia, lymphoma, and multiple...

According to a newly published market research report by 24LifeSciences, global lentiviral packaging kit market was valued at USD 345.2 million in 2024 and is projected to reach USD 752.8 million by 2032, growing at a compound annual growth rate (CAGR) of 10.2% during the forecast period 2025-2032. Lentiviral packaging kits contain essential components to produce lentiviral vectors derived...

" According to the latest report published by Data Bridge Market Research, the U.S. Cancer Treatment Market The U.S. cancer treatment market size was valued at USD 140.75 billion in 2025 and is expected to reach USD 368.91 billion by 2033, at a CAGR of 12.80% during the forecast period. With the effectual use of technology, innovative applications and expertise, U.S. Cancer Treatment...

The United States CAR-T Cell Therapy Market continues to lead global growth, supported by a strong biotechnology ecosystem, advanced healthcare infrastructure, and substantial investments in oncology research. The increasing prevalence of hematological malignancies, growing adoption of personalized cancer therapies, and rising number of regulatory approvals for CAR-T cell products are driving...

The US CAR-T Cell Therapy Market is experiencing exceptional growth due to increasing adoption of personalized cancer treatments, rising incidence of hematological malignancies, and strong investments in cell and gene therapy research. The United States remains a global leader in CAR-T therapy development, supported by advanced healthcare infrastructure, favorable regulatory pathways, and the...